Skip to main content

Table 3 Analysis of serum markers across Left Ventricular Ejection Fraction (LVEF) among ST-Elevation Myocardial Infarction Patients

From: Evaluation of cardiometabolic risk markers linked to reduced left ventricular ejection fraction (LVEF) in patients with ST-elevation myocardial infarction (STEMI)

 

LVEF categories

Normal (n = 35)

Mildly reduced (n = 48)

Moderately reduced (n = 94)

Severely reduced (n = 23)

P value

Fasting blood sugar level (FBS) (mg/dL)

139.00 (70)

159.00 (73.75)

141.00 (97)

212.00 (167)

0.040

Serum Hemoglobin A1C (HbA1c) (%)a

8.75 (2.70)

7.52 (2.78)

8.22 (2.13)

10.22 (1.99)

0.051

High-density lipoprotein cholesterol (HDL-C; mg/dL)

38.00 (6)

38.00 (9)

38.00 (10)

37.00 (13)

0.769

Low-density lipoprotein cholesterol (LDL-C; mg/dL)

97.40 (36.80)

101.30 (51.65)

92.20 (39.40)

94.60 (49.00)

0.467

Total cholesterol (mg/dL)

172.00 (65.00)

167.00 (72.00)

156.00 (46.75)

153.00 (59.00)

0.151

Serum triglyceride level (mg/dL)

142.00 (97.00)

142.50 (78.25)

118.07 (71.75)

95.00 (41.00)

0.001

Serum WBC count/m3

10,200.00 (4500)

10,050.00 (4150)

11,500.00 (5550)

12,900.00 (4900)

0.029

Hemoglobin (g/dL)

13.42 (2.09)

12.94 (1.73)

12.74 (2.26)

12.23 (2.26)

0.189

Serum neutrophil count (%)

70.00 (18.00)

78.50 (17.00)

75.00 (16.00)

83.00 (13.00)

0.002

Serum lymphocyte count (%)

25.00 (15.00)

19.00 (16.25)

21.00 (15.00)

15.00 (13.00)

0.033

neutrophil to lymphocyte ratio (NLR)

2.92 (3.13)

4.01 (3.82)

3.57 (3.32)

5.47 (5.54)

0.021

  1. Data of all variables are presented as median (interquartile range) except for hemoglobin and HbA1c which are reported as mean (standard deviation)
  2. aHBA1c levels were only measured for those who had a history of diabetes (n = 62)